Within the last quarter, Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 8 | 2 | 0 | 0 | 1 |
Last 30D | 0 | 0 | 0 | 0 | 1 |
1M Ago | 4 | 0 | 0 | 0 | 0 |
2M Ago | 4 | 2 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
These 11 analysts have an average price target of $59.0 versus the current price of Harmony Biosciences at $33.13, implying upside.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased